Physicians’ Opinions Survey on FDA’s Bydureon Approval

2012-03-06

Report Description

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Bio-Surfactants Market 2015-2019

Bio-surfactants are an assorted gathering of active molecules that can be produced by integrating living cells or micro-organisms, such as bacteria, fungi, and yeast. Bio-based surfactants can be produced from oleochemical raw materials such as vegetable oils, animal fats, sucrose, and glucose. Due to their excellent foaming, wetting, emulsifying, and detergency traits, bio-surfactants have emerged as the most versatile bio-process chemicals and are widely in various industries such as cosmetics, personal care, bioremediation, pharmaceuticals, agriculture, and food processing. The analysts forecast global bio-surfactants market to grow at a CAGR of 6.14% over the period 2015-2019. Covered in this Report This report covers the present scenario and the growth prospects of the global......
$3000

EMR/EHR Market in the US 2015-2019

An EMR/EHR is defined is a digital version of the traditional paper-based medical record for a patient, which includes the patient's information, history of care, clinical data, and information from multiple sources that are maintained within a hospital, clinic, or health center. Recently, the terms EMR and EHR have been used interchangeably. An EMR/EHR permits a clinician to track data over time, identify patients due for preventative screenings, help check patients on certain parameters such as blood pressure readings or vaccines, and monitor overall quality of care within the practice. An EMR/EHR helps make the process of patient record keeping easier, more accurate, comprehensive, and more efficient. EMR/EHR is one of the best ways to boost patient safety, manage chronic illnesses, and......
$2500

Global Diabetic Retinopathy Market 2015-2019

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involvi......
$2500

Global Hemodialysis Market 2015-2019

Hemodialysis is a procedure in which excess fluids and toxins are mechanically filtered from the blood of individuals when the kidneys are not able to function normally. It is the treatment used when there is an acute and chronic disturbance in the functioning of the kidneys. It plays a major role in improving a patient's quality of life. For hemodialysis, vascular access is needed for blood to flow out of the body to be filtered and pumped by a hemodialysis machine through a dialyzer. Hemodialysis can be performed in an in-center facility or at home. The analysts forecast global hemodialysis market to grow at a CAGR of 4.73% over the period 2015-2019. Covered in this Report The global hemodialysis market is divided into two segments: hemodialysis products and services. The rep......
$2500

Healthcare IT Market in Saudi Arabia 2015-2019

Over the years, businesses in Saudi Arabia have been adopting advanced technologies and IT integration solutions to enhance their operations and revenue. With more and more operations being enabled and enriched by innovative IT applications and solutions, IT has become a key enabler of business functions. This trend is also being witnessed in the healthcare sector in Saudi Arabia. The need to maintain a standard record format has led to the transformation of traditional medical records to electronic health records. Implementation of the policy that makes insurance mandatory is also contributing to the growth of this market. The need to track common ailments has also intensified the need for IT. In addition, the inherent benefits of IT, such as process efficiency, cost-effectiveness, mobili......
$2500

Global Neurodegenerative Diseases Market 2015-2019

According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington's disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer......
$3500

Global Osteoporosis Drugs Market 2015-2019

Osteoporosis, or porous bone, is a disease characterized by low bone density and structural deterioration of bone tissue, leading to fragile bones. As bones becomes fragile, risk of fracture increases. Osteoporosis primarily affects women, but can also affect men. In women, bone loss occurs rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement is too slow. Risk factors for osteoporosis include gender, age, low body weight, ethnicity, and family history. Some of the risk factors that can be manipulated include sex hormones, medication use, intake of calcium and vitamins, alcohol intake, and smoking. The analysts forecast global osteoporosis drugs market to grow at ......
$2500

Global Peritoneal Dialysis Market 2015-2019

Peritoneal dialysis is a needle-free treatment and can be performed either by a patient or with the help of a care partner. It is used to remove waste products and extra fluid from the body during the issue with kidney functions. Peritoneal dialysis differs from hemodialysis as in this treatment the blood is not taken from the body to treat the patient. In peritoneal dialysis, a tube called PD catheter is placed in the belly of the patient, and the dialysis is carried out by sterile fluid flowing through the lining of the belly called the peritoneum. This helps the blood flow into and out of the peritoneal space and the blood is cleansed inside the body. The analysts forecast global peritoneal dialysis market to grow at a CAGR of 4.40% over the period 2014-2019. Covered in this repor......
$2500

Pharmaceutical Packaging Market in Europe 2015-2019

Pharmaceutical packaging products are used to protect pharmaceuticals from contamination by external toxins and microbial activity, and to extend their shelf life. Also, drug manufacturers need to comply with international packaging regulations. Various raw materials such as plastic resins, glass, paper and paperboard, aluminum, and other metals are used in the production of pharmaceutical packaging. They are available as bottles, parenteral containers, blister packs, caps, closures, pre-fillable syringes, and tubes. The key end-customers of these packaging products are manufacturers of pharmaceuticals. The analysts forecast pharmaceutical packaging market in Europe to grow at a CAGR of 7.26 percent over the period 2014-2019. Covered in this report The pharmaceutical packaging mar......
$2500

Telemedicine Market in BRIC 2015-2019

Telemedicine is defined as the application of telecommunication technology to provide clinical healthcare to patients, particularly in remote patient care. There are various technologies and devices such as cameras, internet, satellites, and wireless communication that are used to provide telemedicine services, for instance, videoconferencing. Telemedicine provides clinical care services mainly through two technologies: pre-captured and real-time. Telemedicine helps eliminate distance barriers and improves access to medical services that would often not be easily accessible in rural areas. Moreover, it helps save lives in critical care and emergency situations. The analysts forecast telemedicine market in BRIC to grow at a CAGR of 16.14% over the period 2014-2019. Covered in this rep......
$2500